BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9266689)

  • 1. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives.
    Røjkaer R; Schousboe I
    Eur J Biochem; 1997 Jul; 247(2):491-6. PubMed ID: 9266689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chemical modification of basic amino acid residues on the activation and amidolytic activity of Hageman factor (factor XII).
    Ryder J; Everson B; Jentoft J; Ratnoff OD
    J Lab Clin Med; 1993 Dec; 122(6):697-702. PubMed ID: 8245689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
    Schousboe I; Halkier T
    Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine residues are essential for the surface binding and autoactivation of human coagulation factor XII.
    Samuel M; Samuel E; Villanueva GB
    Biochem Biophys Res Commun; 1993 Feb; 191(1):110-7. PubMed ID: 8447816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-independent acceleration of factor XII activation by zinc ions. II. Direct binding and fluorescence studies.
    Bernardo MM; Day DE; Halvorson HR; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12477-83. PubMed ID: 8509387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis.
    Kato N; Iwanaga S; Okayama T; Isawa H; Yuda M; Chinzei Y
    Thromb Haemost; 2005 Feb; 93(2):359-67. PubMed ID: 15711755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.
    Citarella F; te Velthuis H; Helmer-Citterich M; Hack CE
    Thromb Haemost; 2000 Dec; 84(6):1057-65. PubMed ID: 11154114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII: Hageman factor.
    Pixley RA; Colman RW
    Methods Enzymol; 1993; 222():51-65. PubMed ID: 8412813
    [No Abstract]   [Full Text] [Related]  

  • 9. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor).
    McMullen BA; Fujikawa K
    J Biol Chem; 1985 May; 260(9):5328-41. PubMed ID: 3886654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an inhibitory Zn2+ binding site on the human glycine receptor alpha1 subunit.
    Harvey RJ; Thomas P; James CH; Wilderspin A; Smart TG
    J Physiol; 1999 Oct; 520 Pt 1(Pt 1):53-64. PubMed ID: 10517800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+.
    Schousboe I
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):97-104. PubMed ID: 9518051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of surface-dependent autocatalytic activation of blood coagulation factor XII by divalent metal ions.
    Shore JD; Day DE; Bock PE; Olson ST
    Biochemistry; 1987 Apr; 26(8):2250-8. PubMed ID: 3113477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement.
    Bernardo MM; Day DE; Olson ST; Shore JD
    J Biol Chem; 1993 Jun; 268(17):12468-76. PubMed ID: 8509386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa.
    Cool DE; Edgell CJ; Louie GV; Zoller MJ; Brayer GD; MacGillivray RT
    J Biol Chem; 1985 Nov; 260(25):13666-76. PubMed ID: 3877053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel regulatory metal binding domain is present in the C terminus of Arabidopsis Zn2+-ATPase HMA2.
    Eren E; Kennedy DC; Maroney MJ; Argüello JM
    J Biol Chem; 2006 Nov; 281(45):33881-91. PubMed ID: 16973620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation.
    MacQuarrie JL; Stafford AR; Yau JW; Leslie BA; Vu TT; Fredenburgh JC; Weitz JI
    Blood; 2011 Apr; 117(15):4134-41. PubMed ID: 21304106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
    Schousboe I
    Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman factor).
    Schousboe I
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):671-8. PubMed ID: 7507361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.